Real-World Data of Pyrotinib-Based Therapy in Metastatic HER2-Positive Breast Cancer: Promising Efficacy in Lapatinib-Treated Patients and in Brain Metastasis

Ying Lin,Mingxi Lin,Jian Zhang,Biyun Wang,Zhonghua Tao,Yiqun Du,Sheng Zhang,Jun Cao,Leiping Wang,Xichun Hu 대한암학회 2020 Cancer Research and Treatment Vol.52 No.4

Purpose Pyrotinib is a newly-developed irreversible pan-ErbB receptor tyrosine kinase inhibitor. This study reported the first real-world data of pyrotinib-based therapy in metastatic human epidermal growth factor receptor 2 (HER2)-positive breast cancer (BC), focusing on efficacy in lapatinib-treated patients and in brain metastasis. Materials and Methods One hundred thirteen patients with metastatic HER2-positive BC treated with pyrotinib-based therapy in Fudan University Shanghai Cancer Center under non-clinical trial settings from September 1, 2018 to March 1, 2019 were included. Results Over half patients have received more than two lines of systematic therapy and exposed to two or more kinds of anti-HER2 agents. Most patients received a combined therapy, commonly of pyrotinib plus capecitabine, or vinorelbine or trastuzumab. Median progression-free survival (PFS) was 6.3 months (range, 5.54 to 7.06 months) and objective response rate (ORR) was 29.5%, with two patients (1.9%) achieving complete response. Lapatinib-naïve patients had significantly longer PFS than lapatinib-treated patients (9.0 months vs. 5.4 months, p=0.001). ORR for lapatinib-treated patients was 23.2%. Thirty-one of 113 patients have brain metastasis. Median PFS was 6.7 months and intracranial ORR was 28%. For patients without concurrent radiotherapy and/or brain surgery, the ORR was very low (6.3%). But for patients receiving concurrent radiotherapy and/or brain surgery, the ORR was 66.7%, and three patients achieved complete response. Most common adverse event was diarrhea. Conclusion Pyrotinib-based therapy demonstrated promising effects in metastatic HER2-positive BC and showed activity in lapatinib-treated patients. For patients with brain metastasis, pyrotinib-based regimen without radiotherapy showed limited efficacy, but when combined with radiotherapy it showed promising intracranial control.

Optimization of Blade Profile of a Plenum Fan

Lin Wu,Hua-Shu Dou,Yikun Wei,Yongning Chen,Wenbin Cao,Cunlie Ying 한국유체기계학회 2016 International journal of fluid machinery and syste Vol.9 No.1

A method of optimization design for the blade profile of a centrifugal impeller by controlling velocity distribution is presented, and a plenum fan is successfully designed. This method is based on the inner flow calculation inside the centrifugal impeller, and is related to the distribution of relative velocity. The results show that after optimization, the boundary layer separation on the suction surface has been inhibited and the stability of plenum fan is improved. The flow at the impeller outlet is also studied, and the jet-wake pattern at the impeller outlet is improved obviously by optimization. The calculation result shows that the static pressure and static pressure efficiency can be increased by 15.4% and 21.4% respectively.

A New Field-Assisted Annealing Approach for Advanced Cu-Zr Alloy Metallization

Ying Wang,Fei Cao,Mi-lin Zhang 대한금속·재료학회 2012 ELECTRONIC MATERIALS LETTERS Vol.8 No.5

A new field-assisted annealing approach for Cu-Zr alloy metallization is proposed and investigated. Cu-Zr/SiO2/Si samples were vacuum-annealed at pressure of 2 × 10−3 Pa with (−20 V) and without field-assisted annealing for an hour in 250°C - 400°C temperature range. Based on the XRD, TEM, XPS, and resistivity measurement results, we conclude that the dragging force for Zr atoms in field-assisted annealing samples to the interface shall be larger than that of samples without field-assisted annealing. As a consequence, by low concentration alloy atoms adding and FAA processing, the low Cu alloy film resistivity and thin selfforming barrier layer can be simultaneously obtained at lower temperature.

Production and Characterization of Keratinolytic Proteases by a Chicken Feather-Degrading Thermophilic Strain, Thermoactinomyces sp. YT06

( Lin Wang ),( Yuting Qian ),( Yun Cao ),( Ying Huang ),( Zhizhou Chang ),( Hongying Huang ) 한국미생물생명공학회(구 한국산업미생물학회) 2017 Journal of microbiology and biotechnology Vol.27 No.12

Thermoactinomyces sp. strain YT06 was isolated from poultry compost and observed to degrade integral chicken feathers completely at 60°C, resulting in the formation of 3.24 mg/ml of free amino acids from 50 ml of culture containing 10 g/l chicken feathers. Strain YT06 could grow and secrete keratinase using feather as the only carbon and nitrogen sources without other supplement, but complementation of 10 g/l sucrose and 4 g/l NaNO₃ increased the production of the keratinolytic enzyme. The maximum protease activity obtained was 110 U/ml and for keratinase was 42 U/ml. The keratinase maintained active status over a broad pH (pH 8-11) and temperature (60-75°C). It was inhibited by serine protease inhibitors and most metal ions; however, it could be stimulated by Mn²⁺ and the surfactant Tween-20. A reductive agent (β-mercaptoethanol) was observed to cleave the disulfide bond of keratin and improve the access of the enzyme to the keratinaceous substrate. Zymogram analysis showed that strain YT06 primarily secreted keratinase with a molecular mass of approximately 35 kDa. The active band was assessed by MALDI-TOF mass spectrometry and was observed to be completely identical to an alkaline serine protease from Thermoactinomyces sp. Gus2-1. Thermoactinomyces sp. strain YT06 shows great potential as a novel candidate in enzymatic processing of hard-to-degrade proteins into high-value products, such as keratinous wastes.

Optimization of Blade Profile of a Plenum Fan

Wu, Lin,Dou, Hua-Shu,Wei, Yikun,Chen, Yongning,Cao, Wenbin,Ying, Cunlie Korean Society for Fluid machinery 2016 International journal of fluid machinery and syste Vol.9 No.1

A method of optimization design for the blade profile of a centrifugal impeller by controlling velocity distribution is presented, and a plenum fan is successfully designed. This method is based on the inner flow calculation inside the centrifugal impeller, and is related to the distribution of relative velocity. The results show that after optimization, the boundary layer separation on the suction surface has been inhibited and the stability of plenum fan is improved. The flow at the impeller outlet is also studied, and the jet-wake pattern at the impeller outlet is improved obviously by optimization. The calculation result shows that the static pressure and static pressure efficiency can be increased by 15.4% and 21.4% respectively.

Effects of Endogenous Hormones on Variation of Shoot Branching in a Variety of Non-heading Chinese Cabbage and Related Gene Expression

Xue-Wei Cao,Hong-Mi Cui,Yuan Yao,Ai-Sheng Xiong,Xi-Lin Hou,Ying Li 한국식물학회 2017 Journal of Plant Biology Vol.60 No.4

Shoot branching (tillering) primarily determinesplant shoot architecture and has been studied in many plants. Shoot branching is an important trait in non-heading Chinesecabbage (Brassica rapa ssp. chinensis Makino). The B. rapassp. chinensis var. multiceps exhibits unique and multipleshoot branching characteristics. Here, we analyzed the variationin shoot branching between ‘Maertou,’ with multiple shootbranching, and ‘Suzhouqing,’ a common variety. The levelsof endogenous indole-3-acetic acid (IAA), zeatin ribosideand active gibberellins in the shoot meristem tissues of thetwo cultivars were quantified by enzyme-linked immunosorbentassay during the vegetative growth stage. High levels of IAAmaintained axillary bud dormancy and repressed axillary budoutgrowth allowing shoot branching to form in the vegetativestage in ‘Suzhouqing.’ In contrast, low levels of IAA did notinhibit axillary buds in ‘Maertou,’ while a high level of cytokininpromoted axillary bud growth and branch shoot development. Exogenous hormone (rac-GR24 and 6-benzylaminopurine)treatment showed that ‘Maertou’ was relatively sensitive tocytokinin, because the fold changes of cytokinin-responsivegenes in ‘Maertou’ were significantly more frequent than thosein ‘Suzhouqing’. Cytokinin was the direct regulator for axillarybud growth of ‘Maertou’. Compared with ‘Suzhouqing’,‘Maertou’ was sensitive to cytokinin and this weakened thestrigolactone–cytokinin branching pathway.

Allogeneic Hemopietic Stem Cell Transplants for the Treatment of B Cell Acute Lymphocytic Leukemia

Dong, Wei-Min,Cao, Xiang-Shan,Wang, Biao,Lin, Yun,Hua, Xiao-Ying,Qiu, Guo-Qiang,Gu, Wei-Ying,Xie, Xiao-Bao Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.15

Objective: Explore the feasibility of allo-hemopietic stem cell transplants in treating patients with B cell acute lymphocytic leukemia. Methods: Between september 2006 and February 2011, fifteen patients with B cell acute lymphocytic leukemia (ALL) were treated by allo-hemopietic stem cell transplants (HSCT). Stem cell sources were peripheral blood. Six patients were conditioned by busulfan (BU) and cyclophosphamide (CY) and nine patients were conditioned with TBI and cyclophosphamide (CY). Graft versus host disease (GVHD) prophylaxis regimen consisted of cyclosporine A (CSA), methotrex ate (MTX) and mycophenolatemofetil (MMF). Results: Patients received a median of $7.98{\times}10^8{\cdot}kg^{-1}$ ($5.36-12.30{\times}10^8{\cdot}kg^{-1}$) mononuclear cells (MNC). The median time of ANC> $0.5{\times}10^9/L$ was day 12 (10-15), and PLT> $20.0{\times}10^9/L$ was day 13 (11-16). Extensive acute GVHD occurred in 6 (40.0%) patients, and extensive chronic GVHD was recorded in 6 (40.0%) patients. Nine patients were alive after 2.5-65 months follow-up. Conclusion: Allogeneic stem cell transplant could be effective in treating patients with B cell acute lymphocytic leukemia.

Employing rotating vaneless diffuser to enhance the performance of plenum fan

Dou, Hua-Shu,Wu, Lin,Wei, Yikun,Chen, Yongning,Cao, Wenbin,Ying, Cunlie Korean Society for Fluid machinery 2017 International journal of fluid machinery and syste Vol.10 No.1

Numerical simulation is carried out for flow characteristics in a plenum fan and the influence of the diameter ratio of the rotating vaneless diffuser on the performance of plenum fan is analyzed. The diameter ratio of the rotating vaneless diffuser employed is from 1.03 to 1.3. The research results show that the rotating vaneless diffuser is able to enhance the performance of plenum fan. It is found that there is significant improvement in static pressure and efficiency at the diameter ratio of 1.05 at high flow coefficients, while the optimal diameter ratio is 1.2 at rated and low flow coefficient.

Employing rotating vaneless diffuser to enhance the performance of plenum fan

Hua-Shu Dou,Lin Wu,Yikun Wei,Yongning Chen,Wenbin Cao,Cunlie Ying 한국유체기계학회 2017 International journal of fluid machinery and syste Vol.10 No.1

Numerical simulation is carried out for flow characteristics in a plenum fan and the influence of the diameter ratio of the rotating vaneless diffuser on the performance of plenum fan is analyzed. The diameter ratio of the rotating vaneless diffuser employed is from 1.03 to 1.3. The research results show that the rotating vaneless diffuser is able to enhance the performance of plenum fan. It is found that there is significant improvement in static pressure and efficiency at the diameter ratio of 1.05 at high flow coefficients, while the optimal diameter ratio is 1.2 at rated and low flow coefficient.

Leucogen Tablets at 60 mg Three Times per Day are Safe and Effective to Control Febrile Neutropenia

Huang, Xin-En,Cao, Jie,Qian, Zhi-Ying,Xu, Xia,Shi, Lin,Wu, Xue-Yan,Liu, Jin,Wang, Lin Asian Pacific Journal of Cancer Prevention 2014 Asian Pacific journal of cancer prevention Vol.15 No.19

Purpose: To investigate whether it is safe to use leucogen tablets 60 mg three times per day (180 mg for a day) and whether this regimen could reduce the incidence of febrile neutropenia caused by chemotherapy. Methods: This prospectively designed study focused on the safety and effectiveness of leucogen tablets 60mg three times per day for a group of cancer patients during chemotherapy for mainly lung or gastric cancers. The tablets were administered from 5 days before until the termination of chemotherapy. Neutropenia and other healthcare encounters were defined as events and occurrence was estimated for comparison. Results: We identified 39 patients receiving leucogen tablets 60mg three times per day, including 11 with gastric, 12 with lung and 16 with other sites of cancer. The mean age was 65 (29-75) years and there were 27 male and 12 female patients. The mean duration of leucogen tablets intake was 59 days. Eighteen patients were treated with taxane-based, 4 with irinotecan-based and 17 with other chemotherapy. The incidence of febrile neutropenia was 0%. Twelve patients were found severe neutropenia (grade III/IV), and the duration of severe neutropenia (grade III/IV) was 5 days. Treatment-emergent adverse events were attributable to complications of myelosuppressive chemotherapy or the primary disease (i.e., alopecia, nausea, asthenia, neutropenia, and severe hepatic renal dysfunction). No chemotherapy was delayed and no treatment related death was observed. Conclusions: This study suggested that leucogen tablets 60mg three times per day (180mg for a day) are safe and could be effective for preventing febrile neutropenia in patients with chemotherapy.